心房颤动急性发作的处理

doi:10.3969/j.issn.1004-583X.2016.01.006

临床荟萃 ›› 2016, Vol. 31 ›› Issue (1): 22-26.doi: 10.3969/j.issn.1004-583X.2016.01.006

心房颤动急性发作的处理

刘红彬¹, 王晓燕¹, 张志刚², 籍振国¹

1.河北医科大学附属石家庄市第三医院心内科, 河北石家庄 050011;
2. 石家庄市建北社区卫生服务中心, 河北石家庄 050011

收稿日期:2015-10-10 出版日期:2016-01-05 发布日期:2016-04-19
通讯作者: 刘红彬, Email:13323110522@126.com
作者简介:刘红彬,主任医师,医学硕士,河北省医学会起搏及电生理分会委员。长期从事临床心律失常的诊治,擅长射频消融治疗快速型心律失常,起搏器治疗缓慢型心律失常等心律失常介入治疗。

Treatment of acute atrial fibrillation

Liu Hongbin¹, Wang Xiaoyan¹, Zhang Zhigang², Ji Zhenguo¹

1.Department of Cardiology,the Third Hospital of Shijiazhuang,Shijiazhuang 050011,China;
2. Jianbei Community Health Center of Shijiazhuang, Shijiazhuang 050011,China

Received:2015-10-10 Online:2016-01-05 Published:2016-04-19
Contact: Liu Hongbin, Email:13323110522@126.com

摘要/Abstract

摘要： 心房颤动(房颤)的急性发作是指房颤发作时间≤48小时、患者症状明显或血流动力学不稳定,以快速的心室率为特点,易导致心力衰竭、卒中、猝死等危险,因此需要紧急处理。房颤急性期的处理要根据伴随的原发疾病及诱因、血流动力学是否稳定以及房颤的持续时间制定个体化的治疗方案。

关键词: 心房颤动, 血流动力学, 治疗方案

Abstract: Acute atrial fibrillation defines the patients with atrial fibrillation which continue less than 48 hours, and the patients present obvious symptom or hemodynamic instability. The feature of acute atrial fibrillation is rapid ventricular rate, which may result in dangerous complications such as heart failure, stroke, sudden death and so on. Therefore, we should give urgent treatment for the patients. The treatment of acute atrial fibrillation should base on factors of original diseases, inducement, hemodynamic stability or not and the duration of fibrillation, which are helpful for individualized treatment plan.

Key words: acute atrial fibrillation, hemodynamic, treatment plan

中图分类号:

R541.75

刘红彬, 王晓燕, 张志刚, 籍振国. 心房颤动急性发作的处理[J]. 临床荟萃, 2016, 31(1): 22-26.

Liu Hongbin, Wang Xiaoyan, Zhang Zhigang, Ji Zhenguo. Treatment of acute atrial fibrillation[J]. Clinical Focus, 2016, 31(1): 22-26.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2016.01.006

https://huicui.hebmu.edu.cn/CN/Y2016/V31/I1/22

参考文献

[1] 霍本良,潘庆丽,李月娟. 58例非瓣膜病心房颤动致脑梗死的临床、CT/MRI分析[J]. 临床荟萃,2015(10):70-73.
[2] Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis[J]. Am J Cardiol, 1998, 82(12):1545-1547.
[3] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation[J]. JACC, 2014, 3(22): 1010-1016.
[4] Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)[J]. Europace, 2010,12(10):1360-1420.
[5] Kowey PR, VanderLugt JT, Luderer JR. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter[J]. Am J Cardiol, 1996, 78(8): 46-52.
[6] Kumar A. Intravenous amiodarone therapy for atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function[J]. South Med J, 1996, 89:779-785.
[7] Le Heuzey JY, De Ferrari GM, Radzik D, et al. A short-term, randomized,double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study[J]. J Cardiovasc Electrophysiol, 2010, 21(6):597-605.
[8] Kober L, Torp-Pedersen C, McMurray JJ, et al. Increased mortality after dronedarone therapy for severe heart failure[J]. N Engl J Med, 2008, 358(6):2678-2687.
[9] Capucci A, Villani GQ, Aschieri D,et al. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation[J]. Eur Heart J, 2000, 21(1):66-73.
[10] Maffè S, Paffoni P, Perucca A, et al. Effects of pretreatment with amiodarone infusion in patients with persistent atrial fibrillation submitted to external electrical cardioversion: a single center experience[J]. Gi Ital Card (Rome), 2008, 9(7):504-508.
[11] 游斌权,邢杨波,郭航远,等.老年人慢性心房颤动导管消融治疗的疗效及安全性[J].河北医科大学学报,2012,33(5):604-606.
[12] 于海波,王冬梅,梁迎春,等.除颤电极导线故障判断与植入起搏感知电极的处理效果[J].临床误诊误治,2015,28(10):86-89.
[13] 杨艳敏,颜红兵,朱俊,等.解读美国心脏协会/美国心脏病学学会/心律学会最新心房颤动治疗指南[J].中华心血管病杂志,2014,42(11):971-973.
[14] 冯晓云.急性心肌梗死合并不同心室率心房颤动的预后分析[J].临床荟萃,2013,28(9):76-77.
[15] Hobbs WJ, Fynn S, Todd DM, et al. Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans[J]. Circulation, 2000, 101(10):1145-1151.
[16] Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation[J]. N Engl J Med, 2010, 362(4):1363-1373.
[17] Groenveld HF, Crijns HJ, Van den Berg MP,et al. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE Ⅱ (Rate Control Efficacy in Permanent Atrial Fibrillation II) study[J]. J Am College Cardiol, 2011, 58(7):1795-1803.
[18] Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis[J]. Ann Internal Med, 2002, 137(9):715-725.
[19] Fernando HC, Jaklitsch MT, Walsh GL, et al. The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary[J]. Ann Thorac Surg, 2011, 92(3):1144-1152.
[20] Jason G, Andrade MD, Kenneth Gin, MD. et al. How to optimize rate control in clinical atrial fibrillation management[J]. CJC, 2013, 29 (10):1299-1301.

心房颤动急性发作的处理

Treatment of acute atrial fibrillation

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王奕涵, 秦旭雁, 韩宣泽, 王樱洁, 高菲菲, 陈春红, 张岭楠, 张芳. 利伐沙班用于HASBLED评分≥3分的高龄非瓣膜性心房颤动患者的有效性和安全性[J]. 临床荟萃, 2024, 39(2): 121-124.
[2]	李雯琳, 张志. 心房颤动患者左心耳形态结构和功能与左心耳血栓及心源性卒中的关系研究进展[J]. 临床荟萃, 2024, 39(2): 168-171.
[3]	赵浩天, 李丽. 肺超声在心脏急重症疾病合并肺水肿中应用的研究进展[J]. 临床荟萃, 2023, 38(9): 832-837.
[4]	武锐锋, 刘宇宏. PDZ结合激酶/T淋巴细胞因子激活的杀伤细胞源性蛋白激酶的作用机制及其在肿瘤治疗中的潜在价值[J]. 临床荟萃, 2023, 38(8): 763-768.
[5]	王震, 杨晓月, 李少杰, 王贤, 陈淑霞, 谷剑. 射血分数保留的心力衰竭合并心房颤动患者临床特征及再入院危险因素[J]. 临床荟萃, 2023, 38(4): 308-314.
[6]	张芳, 张伊超, 贾辛未, 李建龙, 陈春红. 心房颤动高CHA2DS2-VASc评分≥75岁住院患者随访1年结果分析[J]. 临床荟萃, 2023, 38(2): 117-120.
[7]	马静红, 杨倩, 贾永建, 党懿. 心房颤动导管消融围术期不间断新型口服抗凝剂和不间断华法林抗凝导致心脏压塞风险的荟萃分析[J]. 临床荟萃, 2022, 37(9): 773-778.
[8]	张海福, 叶向晴, 陈者旭, 陈施鉴, 杨栋, 张邢炜. 适量运动对心房颤动患者预后的影响:系统综述与Meta分析[J]. 临床荟萃, 2022, 37(6): 485-489.
[9]	章敬水, 徐亚男, 王钧, 杨毅, 姜海兵, 唐龙, 王贤平, 邵名亮. 新发的不同类型心力衰竭合并心房颤动的临床特点和远期预后分析[J]. 临床荟萃, 2022, 37(6): 504-509.
[10]	李卫伟, 李亚男. 左房容积指数用于预测心房颤动患者射频消融后复发的meta分析[J]. 临床荟萃, 2022, 37(11): 965-968.
[11]	安景景, 王小娟, 邓爱云. 预激综合征伴心房颤动射频消融术后心房颤动复发率的meta分析[J]. 临床荟萃, 2022, 37(10): 899-904.
[12]	曹晶晶, 张英杰, 常丽娟. 心房颤动发病机制及相关生物标志物研究进展[J]. 临床荟萃, 2022, 37(10): 946-949.
[13]	陈礼龙, 刘务朝, 司秋艳, 张建平, 程荣, 吴权. 不同剂量硫酸氢氯吡格雷对脑梗死患者血流动力学指标及血清miR-191、miR-18a水平的影响[J]. 临床荟萃, 2021, 36(7): 608-611.
[14]	赵美丽, 肖立远, 刘林, 康超, 张秋香. NT-proBNP、hs-CRP、LAD与慢性心力衰竭合并心房颤动的相关性[J]. 临床荟萃, 2021, 36(5): 412-415.
[15]	霍晓霞, 牛巍巍, 韩旭, 张晓岚. 密集套扎对食管静脉曲张出血患者肝功能及血流动力学的影响[J]. 临床荟萃, 2021, 36(3): 238-241.